We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$62.6M
Cap. Flow
-$68.5M
Cap. Flow %
-6%
Top 10 Hldgs %
20.56%
Holding
206
New
27
Increased
44
Reduced
47
Closed
29

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$19M
2
AXSM icon
Axsome Therapeutics
AXSM
+$12M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.2M
4
CHX
ChampionX
CHX
+$11M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.5M

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$15.9M
2
UTHR icon
United Therapeutics
UTHR
+$14.3M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.4M
4
STAA icon
STAAR Surgical
STAA
+$11.7M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.14%
2 Technology 14.06%
3 Industrials 9.62%
4 Energy 8.22%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KKR.PRC
51
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
– –
0
– –
WCN
52
Waste Connections
WCN
$42B
$7.53M 0.66%
56,832
– –
THS
53
DELISTED
Treehouse Foods
THS
$6.89M 0.6%
139,500
-117,202
-46% -$5.58M
VICI icon
54
VICI Properties
VICI
$29.4B
$6.88M 0.6%
212,337
+8,403
+4% +$270K
NVDA icon
55
NVIDIA
NVDA
$5.42T
$6.59M 0.58%
450,870
+94,770
+27% +$1.39M
ARES icon
56
Ares Management
ARES
$30.9B
$6.58M 0.58%
96,105
– –
CDNS icon
57
Cadence Design Systems
CDNS
$93.4B
$6.34M 0.56%
39,483
+6,460
+20% +$1.03M
WMB icon
58
Williams Companies
WMB
$86.1B
$6.22M 0.54%
189,000
– –
SNPS icon
59
Synopsys
SNPS
$79.7B
$6.08M 0.53%
19,038
+1,197
+7% +$375K
PCVX icon
60
Vaxcyte
PCVX
$8.64B
$5.91M 0.52%
+123,322
New +$4.84M
DSGX icon
61
Descartes Systems
DSGX
$6.82B
$5.85M 0.51%
83,982
-5,420
-6% -$370K
MGPI icon
62
MGP Ingredients
MGPI
$375M
$5.82M 0.51%
54,707
-373
-0.7% -$41.7K
SYM icon
63
Symbotic
SYM
$5.22B
$5.81M 0.51%
486,356
+291,443
+150% +$3.4M
BKR icon
64
Baker Hughes
BKR
$61.1B
$5.71M 0.5%
+193,234
New +$5.33M
CWST icon
65
Casella Waste Systems
CWST
$5.69B
$5.6M 0.49%
70,560
-691
-1% -$55.5K
MTDR icon
66
Matador Resources
MTDR
$6.09B
$5.46M 0.48%
95,432
-895
-0.9% -$56.5K
ESTC icon
67
Elastic
ESTC
$7.81B
$5.42M 0.48%
105,261
-13,572
-11% -$813K
BAH icon
68
Booz Allen Hamilton
BAH
$9.15B
$5.12M 0.45%
48,940
– –
BOOT icon
69
Boot Barn
BOOT
$4.95B
$5.05M 0.44%
+80,702
New +$4.84M
KRNT icon
70
Kornit Digital
KRNT
$791M
$5.03M 0.44%
219,158
+32,178
+17% +$804K
AMRC icon
71
Ameresco
AMRC
$1.36B
$4.78M 0.42%
83,644
-430
-0.5% -$26.2K
DKS icon
72
Dick's Sporting Goods
DKS
$18.7B
$4.74M 0.41%
39,364
-58,615
-60% -$6.6M
KLAC icon
73
KLA
KLAC
$259B
$4.57M 0.4%
121,170
-10,380
-8% -$362K
ISEE
74
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.5M 0.39%
209,976
– –
ASML icon
75
ASML
ASML
$669B
$4.4M 0.39%
8,056
-1,001
-11% -$524K
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Nicholas Investment Partners held 206 positions worth $1.14B, up 5.8% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $68.5M in Q4 2022, closing 29 positions and reducing 47 holdings. Its most notable exit was SpringWorks Therapeutics, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Lantheus worth $15.7M.

  • Nicholas Investment Partners's largest Q4 2022 buy was Lantheus: 308,295 shares worth $15.7M.
  • Nicholas Investment Partners added most to Wintrust Financial in Q4 2022, an estimated $5.83M increase.
  • Nicholas Investment Partners's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $13.4M.
  • Nicholas Investment Partners fully exited SpringWorks Therapeutics in Q4 2022, selling an estimated $15.9M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2022.
  • Nicholas Investment Partners opened 27 new positions and closed 29 in Q4 2022.
  • Nicholas Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.